Choose calculator
Paediatric (ESRA/ASRA 2018): single-shot bolus caps as above; continuous infusion — bupivacaine/levobupivacaine ≤0.2 mg/kg/hr if ≤6 months, ≤0.4 mg/kg/hr if older; ropivacaine ≤0.2 (0–4 mo), ≤0.3 (5–12 mo), ≤0.4 mg/kg/hr (>12 mo). Infants <6 months: additional ~30% reduction (higher free fraction, lower clearance). High-risk: reduce a further ~50%. Amino-amide short-acting/ester agents are not used for continuous infusion here.
Values pending clinical review. Sources: Suresh S, et al. ESRA/ASRA recommendations, Reg Anesth Pain Med 2018; BNF for Children; product information.